Search

Researchers at Tianjin University in China have conducted a study comparing three mass spectrometry methodologies for profiling bacterial protein composition. The study found that bottom-up proteomics provided the highest protein coverage, while MALDI protein fingerprinting demonstrated superior detection reproducibility. The research aims to guide the selection of appropriate profiling strategies for various analytical purposes, including infection diagnosis and pharmaceutical target discovery. This study has been peer-reviewed and offers valuable insights into protein profiling methodologies in the field of Bacterial Infections and Mycoses. [Extracted from the article]

A report from Tianjin University in the People's Republic of China discusses the development of a multifunctional nanomotor targeting beta-amyloid protein in Alzheimer's disease. The nanomotor, called ERCD-1, demonstrated potent inhibitory capabilities and disaggregation of amyloid fibrils under near-infrared light. This research opens new possibilities for the design of nanomotors for Alzheimer's disease theranostics. [Extracted from the article]

Researchers at Tianjin University have published a new report on zwitterionic peptides, which are electrically neutral peptides composed of charged residues. These peptides combine the advantages of zwitterionic materials and biological peptides, making them attractive for various applications in materials science, biomedicine, and biochemistry. The study outlines the development, mechanisms, design strategies, and recent applications of zwitterionic peptides, emphasizing their potential in functional coatings, biosensors, drug delivery systems, and engineering proteins. The research aims to provide clarity and insight into the design and applications of zwitterionic peptides, offering future research perspectives and challenges in this field. [Extracted from the article]

A study conducted at Tianjin Medical University in China explores the use of a bioinspired glycopeptide hydrogel loaded with minocycline hydrochloride to address periodontitis. The hydrogel demonstrated antimicrobial effects, inhibited alveolar bone resorption, and promoted bone regeneration in a rat model of periodontitis. The research suggests that this approach could offer a promising therapeutic strategy for treating periodontitis by regulating bone homeostasis. Financial support for the study was provided by various organizations, including the National Natural Science Foundation of China. [Extracted from the article]

Researchers at Tianjin University in China have developed a new approach to treating Alzheimer's disease using serum albumin-embedded copper nanoclusters. These nanoclusters demonstrated the ability to inhibit the aggregation of beta-amyloid fibrils and reduce neuroinflammation associated with the disease. The study, supported by the National Natural Science Foundation of China, showed promising results in inhibiting key pathological hallmarks of Alzheimer's disease. The findings suggest a potential new treatment strategy for this neurodegenerative condition. [Extracted from the article]

A study conducted at Tianjin Medical University in China has shed light on the mechanism of hepatitis B virus (HBV) cccDNA persistence, which is a major obstacle in anti-HBV therapy. The researchers found that cucurbitacin I, a compound that targets the transcriptional factor STAT3, effectively limited the stability of HBV cccDNA and replication. They also identified that the E3 ubiquitin ligase DTX4 and male-specific lethal 2 (MSL2) play a role in enhancing the stability of HBV cccDNA by facilitating the degradation of APOBEC3B through ubiquitination. These findings provide new insights into the mechanism of HBV cccDNA and suggest potential therapeutic targets. [Extracted from the article]

A study conducted in Tianjin, People's Republic of China, explored the potential effects of lentinan, a natural product commonly used in medicine and dietary supplements, on Alzheimer's disease (AD) and Parkinson's disease (PD). The study found that lentinan inhibited the formation of beta-amyloid and alpha-synuclein fibers, which are associated with the pathogenesis of AD and PD, respectively. Lentinan also protected against damage caused by the accumulation of these proteins and demonstrated beneficial effects in AD and PD mice. The research suggests that lentinan may have potential therapeutic applications for neurodegenerative diseases. [Extracted from the article]

A study conducted by researchers at Tianjin University of Traditional Chinese Medicine in China has identified potential therapeutic targets for diabetic kidney disease (DKD). The study used Mendelian randomization and colocalization analyses to examine the causal relationship between plasma proteins and DKD. The researchers identified 21 blood proteins that may be associated with DKD, with 12 of them showing a causal relationship. Four of these proteins were confirmed through external validation. The study suggests that targeting these proteins could be a promising approach for treating DKD and calls for further clinical investigations. [Extracted from the article]

A study conducted by researchers at Nankai University in Tianjin, China, has found that vitexicarpin, a compound extracted from the fruits of Vitex rotundifolia, has potential anticancer activity against colorectal cancer (CRC). The study investigated the impact of vitexicarpin on CRC through various experiments and found that it directly binds to inosine monophosphate dehydrogenase 2 (IMPDH2) and promotes c-Myc ubiquitination, leading to the inhibition of epithelial-mesenchymal transition (EMT). Vitexicarpin was also found to hinder the migration and invasion of CRC cells both in vitro and in vivo. These findings provide potential molecular targets for CRC treatment and shed light on new mechanisms for c-Myc regulation in tumors. [Extracted from the article]

A study conducted by the Chinese Academy of Medical Sciences in Tianjin, China, explores the role of miR-17-92 in the activation of NF-kappa B in activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL). The researchers found that miR-17-92 expression was positively correlated with NF-kappa B activity and that it promoted cell growth and resistance to NF-kappa B inhibitors. The study also revealed that miR-17-92 activated NF-kappa B by targeting ubiquitin-editing regulators, leading to constitutive NF-kappa B activation and poorer outcomes in ABC-DLBCL patients. The findings suggest that targeting miR-17-92 could be a potential therapeutic strategy for ABC-DLBCL patients. [Extracted from the article]

A recent study conducted at Tianjin University in China has explored the potential of a novel theranostic nano-agent for the treatment of Alzheimer's disease (AD). The nano-agent, called R-CD-75, was found to inhibit the aggregation of beta-amyloid protein (Aβ) and depolymerize mature Aβ fibrils. It also demonstrated the ability to scavenge reactive oxygen species and image Aβ plaques. In vitro and in vivo studies showed that R-CD-75 mitigated Aβ-induced cytotoxicity and extended the lifespan of AD nematodes. This research highlights the potential of designing carbon dots as potent theranostic agents. [Extracted from the article]

A study conducted by researchers at Tianjin Medical University in China proposes a biomimetic mineralization strategy for remineralizing dental hard tissues. The strategy involves the use of an amyloid-like protein matrix composite with amorphous calcium phosphate (ACP) to form a remineralization layer on damaged dental hard tissue. The study found that this approach effectively repairs enamel and occludes dentinal tubules, with the resulting mineralized layer exhibiting mechanical strength comparable to natural teeth. The research offers potential insights into the mechanisms of biomineral formation and provides a promising material for the treatment of early enamel lesions and dentine hypersensitivity. [Extracted from the article]

A study conducted at Tianjin University in China focused on improving the salt-tolerance of Bacillus amyloliquefaciens for producing lipopeptide under food waste and seawater conditions. The researchers used adaptive laboratory evolution, gene editing, and artificial consortia to enhance the salt-tolerance of the bacteria. The study found that lipopeptide production was significantly increased in the recombinant strain after overexpressing certain genes and replacing the promoter of another gene. The researchers concluded that these findings offer a new strategy for utilizing high-salt food waste and seawater to produce value-added chemicals. [Extracted from the article]

A report from Tianjin Children's Hospital in China discusses a study on acute disseminated encephalomyelitis (ADEM), a common condition in children with myelin oligodendrocyte glycoprotein IgG (MOG-IgG)-associated disease. The researchers aimed to identify genetic variants that distinguish between MOG-IgG-positive ADEM and MOG-IgG-negative ADEM. Through whole exome sequencing analysis, they identified three variants (rs11171951 in NACa, rs231775 in CTLA4, and rs11171951 in GOLGA5) that were significantly different between the two groups. These findings suggest that these variants may serve as novel genetic risk factors for distinguishing between MOG-IgG-positive and MOG-IgG-negative ADEM in a Han Chinese population. [Extracted from the article]

Researchers at Tianjin University in China have reported new data on antimicrobial therapy based on self-assembling peptides. The emergence of drug-resistant microorganisms has become a global health threat, limiting the use of medical materials. The researchers highlight the importance of unconventional therapies that act on new targets or adopt new mechanisms in the era of antibiotic resistance. They discuss the antimicrobial activity of self-assembled peptides, research progress, and assembly strategies. This research has been peer-reviewed and provides valuable insights into the development of antimicrobial peptides. [Extracted from the article]

A study conducted by researchers from Nankai University in Tianjin, China, has found that the antihypertensive drug allisartan can effectively control blood pressure and improve cardiac remodeling and dysfunction in hypertensive rats. The study used spontaneously hypertensive rats as an animal model and treated them with allisartan orally. The researchers found that allisartan lowered blood pressure, attenuated cardiac remodeling, and improved cardiac function. It also reduced cardiomyocyte hypertrophy and cardiac fibrosis. The study suggests that the cardioprotective effect of allisartan may be mediated through the activation of the PI3K-AKT-Nrf2 signaling pathway, upregulation of GSTM2 expression, and reduction of cardiomyocyte apoptosis. [Extracted from the article]

A study conducted at Tianjin University in China has developed a nanovaccine called LaMP-A that co-delivers antigens and adjuvants in a nanoparticle format. The nanovaccine features a metalloprotein core that securely localizes manganese (Mn) and coordinates imidazole-containing adjuvants, resulting in a more stable and physiologically stable vaccine. The research found that the LaMP-A system improves vaccine immunogenicity by exploiting metalloimmune responses via the cGAS-STING pathway. The study demonstrated that immunization with LaMP-A-RBD, using the SARS-CoV-2 receptor-binding domain as a model antigen, elicited strong mucosal, humoral, and cellular immunity. [Extracted from the article]

A report from Nankai University in Tianjin, China discusses the role of genomic island-encoded regulatory proteins in Enterohemorrhagic Escherichia coli (EHEC) O157:H7. EHEC is a zoonotic pathogen that causes foodborne diseases and can lead to diarrhea, colitis, and hemolytic uremic syndrome. The report summarizes the characteristics of these regulatory proteins and their impact on bacterial virulence, motility, and acid resistance. The findings contribute to a better understanding of the pathogenesis of EHEC O157:H7. [Extracted from the article]

A study conducted by the Chinese Academy of Medical Sciences in Tianjin, China, has found that a biomimetic glycopeptide hydrogel can accelerate wound healing by inducing macrophage M2-type polarization. The hydrogel, called GRKgel, promotes a pro-regenerative T cell immune response by enhancing macrophage-T cell crosstalk. The study showed that GRKgel effectively restored the pathological structure and hair follicles in mice, increased the presence of M2 macrophages, and promoted angiogenesis. This research highlights the importance of immune cell crosstalk in promoting tissue regeneration and provides a promising strategy for endogenous tissue regeneration without the use of drugs or stem cells. [Extracted from the article]

A recent study conducted in Tianjin, People's Republic of China, has shed light on the role of CCAAT/enhancer-binding protein beta (CEBPB) in sepsis-induced myocardial injury (SIMI). The researchers found that downregulation of CEBPB alleviated SIMI and inhibited inflammatory responses in macrophages. They also discovered that the ubiquitination modification of CEBPB by constitutive photomorphogenesis protein 1 homolog (COP1) protected the heart against SIMI. These findings suggest that COP1-mediated CEBPB ubiquitination could be a potential therapeutic approach for SIMI in the future. [Extracted from the article]

A study conducted at Nankai University in Tianjin, China, has reported new findings on the use of artificial peptides to promote cell death. The researchers developed a strategy to selectively phosphorylate proteins, activating the necroptotic signaling pathway and inducing cell necroptosis. By designing kinase-biomimetic peptides that mimic the structures of natural necrosomes, the researchers were able to induce specific cytotoxicity in colon cancer cells. This research offers a potential approach to address the challenge of developing targeted drugs for proteins with large interacting surfaces, known as the "undruggable" issue, and provides alternative strategies for overcoming cancer resistance in the future. [Extracted from the article]

Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Emerging Technologies, Health and Medicine, Nanoparticles, Nanotechnology, Neurodegenerative Diseases and Conditions, Peptides and Proteins, Proteins, Tauopathies Keywords for this news article include: Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Emerging Technologies, Health and Medicine, Nanoparticles, Nanotechnology, Neurodegenerative Diseases and Conditions, Peptides and Proteins, Proteins, Tauopathies, Tianjin University. Keywords: Tianjin; People's Republic of China; Asia; Alzheimer Disease; Amyloid; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Emerging Technologies; Health and Medicine; Nanoparticles; Nanotechnology; Neurodegenerative Diseases and Conditions; Peptides and Proteins; Proteins; Tauopathies EN Tianjin People's Republic of China Asia Alzheimer Disease Amyloid Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Emerging Technologies Health and Medicine Nanoparticles Nanotechnology Neurodegenerative Diseases and Conditions Peptides and Proteins Proteins Tauopathies 7121 7121 1 11/06/23 20231111 NES 231111 2023 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Research findings on Neurodegenerative Diseases and Conditions - Alzheimer Disease are discussed in a new report. [Extracted from the article]

Tianjin, People's Republic of China, Asia, Cancer, Emerging Technologies, Health and Medicine, Lipid Research, Lipids, Lipoproteins, Nanosystems, Nanotechnology, Oncology, Peptides and Proteins Keywords: Tianjin; People's Republic of China; Asia; Cancer; Emerging Technologies; Health and Medicine; Lipid Research; Lipids; Lipoproteins; Nanosystems; Nanotechnology; Oncology; Peptides and Proteins EN Tianjin People's Republic of China Asia Cancer Emerging Technologies Health and Medicine Lipid Research Lipids Lipoproteins Nanosystems Nanotechnology Oncology Peptides and Proteins 1559 1559 1 11/06/23 20231107 NES 231107 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Cancer have been published. [Extracted from the article]

Keywords: Tianjin; People's Republic of China; Asia; Alzheimer Disease; Amyloid; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Health and Medicine; Methylene Blue; Neurodegenerative Diseases and Conditions; Peptides and Proteins; Phenothiazines; Proteins; Tauopathies EN Tianjin People's Republic of China Asia Alzheimer Disease Amyloid Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Health and Medicine Methylene Blue Neurodegenerative Diseases and Conditions Peptides and Proteins Phenothiazines Proteins Tauopathies 457 457 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Investigators publish new report on Neurodegenerative Diseases and Conditions - Alzheimer Disease. Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Health and Medicine, Methylene Blue, Neurodegenerative Diseases and Conditions, Peptides and Proteins, Phenothiazines, Proteins, Tauopathies. [Extracted from the article]

Tianjin, People's Republic of China, Asia, Antibodies, Blood Proteins, Clinical Research, Clinical Trials and Studies, Cranial Nerve Diseases and Conditions, Eye Diseases and Conditions, Glycoconjugates, Glycoproteins, Health and Medicine, Immunoglobulins, Immunology, Nervous System Diseases and Conditions, Neuritis, Neuromuscular Diseases and Conditions, Ophthalmology, Optic Nerve Diseases and Conditions, Optic Neuritis, Peptides and Proteins, Peripheral Nervous System Diseases and Conditions, Proteins Keywords for this news article include: Tianjin, People's Republic of China, Asia, Antibodies, Blood Proteins, Clinical Research, Clinical Trials and Studies, Cranial Nerve Diseases and Conditions, Eye Diseases and Conditions, Glycoconjugates, Glycoproteins, Health and Medicine, Immunoglobulins, Immunology, Nervous System Diseases and Conditions, Neuritis, Neuromuscular Diseases and Conditions, Ophthalmology, Optic Nerve Diseases and Conditions, Optic Neuritis, Peptides and Proteins, Peripheral Nervous System Diseases and Conditions, Proteins, Nankai University. [Extracted from the article]

Our news editors obtained a quote from the research from Nankai University, "The binding between the prepared adsorbent and LDL particles simulates the cytosolic lipid droplets to form a lipid-packing structure. According to the news editors, the research concluded: "The excellent blood compatibility plus LDL removal efficiency of PVA@COOH-PE indicates its good application prospect as hemoperfusion adsorbent in the treatment of hyperlipidaemia." Keywords: Tianjin; People's Republic of China; Asia; Drug Research; Bioengineering; Biomembranes; Drugs and Therapies; Health and Medicine; Hemoperfusion; Lipid Research; Lipids; Lipoproteins; Peptides and Proteins; Sorption Detoxification EN Tianjin People's Republic of China Asia Drug Research Bioengineering Biomembranes Drugs and Therapies Health and Medicine Hemoperfusion Lipid Research Lipids Lipoproteins Peptides and Proteins Sorption Detoxification 1953 1953 1 10/24/23 20231027 NES 231027 2023 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Drug Research. [Extracted from the article]

Keywords for this news article include: Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Health and Medicine, Microglia, Neurodegenerative Diseases and Conditions, Neuroglia, Peptides and Proteins, Phagocytosis, Proteins, Risk and Prevention, Tianjin Medical University. Keywords: Tianjin; People's Republic of China; Asia; Alzheimer Disease; Amyloid; Health and Medicine; Microglia; Neurodegenerative Diseases and Conditions; Neuroglia; Peptides and Proteins; Phagocytosis; Proteins; Risk and Prevention EN Tianjin People's Republic of China Asia Alzheimer Disease Amyloid Health and Medicine Microglia Neurodegenerative Diseases and Conditions Neuroglia Peptides and Proteins Phagocytosis Proteins Risk and Prevention 135 135 1 10/03/23 20231006 NES 231006 2023 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Investigators publish new report on Neurodegenerative Diseases and Conditions - Alzheimer Disease. [Extracted from the article]

Together, these results suggest that MED1 inhibited TGFb signaling pathway to reduce cell epithelial-to-mesenchymal transition phenotype and migration through SMAD2 ubiquitination in the metastasis of cutaneous melanoma." Keywords: Tianjin; People's Republic of China; Asia; Cancer; Cutaneous Melanoma; Drugs and Therapies; Genetics; Health and Medicine; Melanoma; Oncology; Peptides and Proteins; Pharmaceuticals; Proteins; Ubiquitins EN Tianjin People's Republic of China Asia Cancer Cutaneous Melanoma Drugs and Therapies Genetics Health and Medicine Melanoma Oncology Peptides and Proteins Pharmaceuticals Proteins Ubiquitins 1318 1318 1 10/03/23 20231006 NES 231006 2023 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on Oncology - Cutaneous Melanoma are discussed in a new report. [Extracted from the article]

Keywords: Tianjin; People's Republic of China; Asia; Antibodies; Antineoplastics; Biomedicine; Blood Proteins; Cell Transplantation; Cell Transplants; Globulins; Immunoglobulins; Immunology; Peptides and Proteins; Proteins; Surgery; Transplant Medicine EN Tianjin People's Republic of China Asia Antibodies Antineoplastics Biomedicine Blood Proteins Cell Transplantation Cell Transplants Globulins Immunoglobulins Immunology Peptides and Proteins Proteins Surgery Transplant Medicine 704 704 1 10/03/23 20231006 NES 231006 2023 OCT 8 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Investigators publish new report on Transplant Medicine - Cell Transplants. Tianjin, People's Republic of China, Asia, Antibodies, Antineoplastics, Biomedicine, Blood Proteins, Cell Transplantation, Cell Transplants, Globulins, Immunoglobulins, Immunology, Peptides and Proteins, Proteins, Surgery, Transplant Medicine. [Extracted from the article]

Keywords: Tianjin; People's Republic of China; Asia; Alzheimer Disease; Amyloid; Biomarkers; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Diagnostics and Screening; Health and Medicine; Neurodegenerative Diseases and Conditions; Peptides and Proteins; Proteins; Tauopathies EN Tianjin People's Republic of China Asia Alzheimer Disease Amyloid Biomarkers Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Diagnostics and Screening Health and Medicine Neurodegenerative Diseases and Conditions Peptides and Proteins Proteins Tauopathies 397 397 1 09/19/23 20230923 NES 230923 2023 SEP 18 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Data detailed on Neurodegenerative Diseases and Conditions - Alzheimer Disease have been presented. Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Biomarkers, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Diagnostics and Screening, Health and Medicine, Neurodegenerative Diseases and Conditions, Peptides and Proteins, Proteins, Tauopathies. [Extracted from the article]

Keywords: Tianjin; People's Republic of China; Asia; Alzheimer Disease; Amyloid; Biomarkers; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Diagnostics and Screening; Health and Medicine; Neurodegenerative Diseases and Conditions; Peptides and Proteins; Proteins; Tauopathies EN Tianjin People's Republic of China Asia Alzheimer Disease Amyloid Biomarkers Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Diagnostics and Screening Health and Medicine Neurodegenerative Diseases and Conditions Peptides and Proteins Proteins Tauopathies N.PAG N.PAG 1 09/19/23 20230922 NES 230922 2023 SEP 23 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Data detailed on Neurodegenerative Diseases and Conditions - Alzheimer Disease have been presented. Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Biomarkers, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Diagnostics and Screening, Health and Medicine, Neurodegenerative Diseases and Conditions, Peptides and Proteins, Proteins, Tauopathies. [Extracted from the article]

The news reporters obtained a quote from the research from Nankai University, "In order to mitigate the neurotoxicity induced by sA beta s and achieve enhanced AD therapeutic outcomes, robust sA beta s clearance become an emerging task. Keywords for this news article include: Tianjin, People's Republic of China, Asia, Amyloid, Peptides and Proteins, Proteins, Nankai University. Keywords: Tianjin; People's Republic of China; Asia; Amyloid; Peptides and Proteins; Proteins EN Tianjin People's Republic of China Asia Amyloid Peptides and Proteins Proteins 824 824 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on Peptides and Proteins - Amyloid have been published. [Extracted from the article]

Keywords for this news article include: Tianjin, People's Republic of China, Asia, Amyloid, Cells, Genetics, Neurons, Peptides and Proteins, Proteins, Nankai University. Tianjin, People's Republic of China, Asia, Amyloid, Cells, Genetics, Neurons, Peptides and Proteins, Proteins Keywords: Tianjin; People's Republic of China; Asia; Amyloid; Cells; Genetics; Neurons; Peptides and Proteins; Proteins EN Tianjin People's Republic of China Asia Amyloid Cells Genetics Neurons Peptides and Proteins Proteins 246 246 1 05/29/23 20230602 NES 230602 2023 JUN 2 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Current study results on Peptides and Proteins - Amyloid have been published. [Extracted from the article]

Keywords: Tianjin; People's Republic of China; Asia; Alzheimer Disease; Amyloid; Brain Diseases and Conditions; Central Nervous System Diseases and Conditions; Dementia; Emerging Technologies; Health and Medicine; Nanoparticles; Nanotechnology; Neurodegenerative Diseases and Conditions; Peptides and Proteins; Proteins; Tauopathies EN Tianjin People's Republic of China Asia Alzheimer Disease Amyloid Brain Diseases and Conditions Central Nervous System Diseases and Conditions Dementia Emerging Technologies Health and Medicine Nanoparticles Nanotechnology Neurodegenerative Diseases and Conditions Peptides and Proteins Proteins Tauopathies 2023 MAR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- New research on Neurodegenerative Diseases and Conditions - Alzheimer Disease is the subject of a report. Tianjin, People's Republic of China, Asia, Alzheimer Disease, Amyloid, Brain Diseases and Conditions, Central Nervous System Diseases and Conditions, Dementia, Emerging Technologies, Health and Medicine, Nanoparticles, Nanotechnology, Neurodegenerative Diseases and Conditions, Peptides and Proteins, Proteins, Tauopathies. [Extracted from the article]

Tianjin, People's Republic of China, Asia, Genetics, Nerve Tissue Proteins, Neuropeptides, Peptides and Proteins, Proteins, Transcription Factors Keywords: Tianjin; People's Republic of China; Asia; Genetics; Nerve Tissue Proteins; Neuropeptides; Peptides and Proteins; Proteins; Transcription Factors EN Tianjin People's Republic of China Asia Genetics Nerve Tissue Proteins Neuropeptides Peptides and Proteins Proteins Transcription Factors 2023 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Proteins - Transcription Factors. [Extracted from the article]